Based on the role of TRAP1 in promoting a multidrug-resistant phenotype, combined targeting of TRAP1 and treatment with chemotherapeutic drugs may exert synergistic anticancer activity toward a broad range of human malignant tumors. This evidence concerns the gene TRAP1 and cancer.